John Weber Denninger, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mind-Body Therapies | 11 | 2024 | 291 | 1.700 |
Why?
|
| Resilience, Psychological | 8 | 2024 | 804 | 1.120 |
Why?
|
| Relaxation Therapy | 5 | 2018 | 181 | 0.870 |
Why?
|
| Burnout, Professional | 4 | 2019 | 712 | 0.780 |
Why?
|
| Internal Medicine | 3 | 2018 | 1056 | 0.770 |
Why?
|
| Relaxation | 6 | 2018 | 51 | 0.650 |
Why?
|
| Meditation | 4 | 2015 | 257 | 0.610 |
Why?
|
| Widowhood | 1 | 2017 | 51 | 0.580 |
Why?
|
| Psychiatry | 3 | 2018 | 1714 | 0.540 |
Why?
|
| Internship and Residency | 5 | 2021 | 5952 | 0.530 |
Why?
|
| Grief | 1 | 2017 | 255 | 0.490 |
Why?
|
| Social Behavior | 2 | 2011 | 1144 | 0.460 |
Why?
|
| Medicine | 1 | 2021 | 946 | 0.430 |
Why?
|
| Stress, Psychological | 10 | 2020 | 4538 | 0.410 |
Why?
|
| Depressive Disorder, Major | 11 | 2017 | 4816 | 0.390 |
Why?
|
| Adaptation, Psychological | 5 | 2020 | 2665 | 0.370 |
Why?
|
| Citalopram | 2 | 2011 | 403 | 0.370 |
Why?
|
| Psychotherapy, Group | 2 | 2014 | 414 | 0.360 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 454 | 0.330 |
Why?
|
| Students | 2 | 2020 | 1751 | 0.320 |
Why?
|
| Guanylate Cyclase | 2 | 2000 | 206 | 0.310 |
Why?
|
| Community Health Services | 1 | 2014 | 659 | 0.310 |
Why?
|
| Movement | 1 | 2015 | 1489 | 0.310 |
Why?
|
| Social Support | 2 | 2017 | 2195 | 0.300 |
Why?
|
| Curriculum | 2 | 2021 | 3778 | 0.300 |
Why?
|
| Fluoxetine | 3 | 2006 | 735 | 0.290 |
Why?
|
| Depression | 5 | 2018 | 8235 | 0.260 |
Why?
|
| Somatoform Disorders | 2 | 2006 | 425 | 0.260 |
Why?
|
| Physicians | 4 | 2019 | 4615 | 0.250 |
Why?
|
| Anxiety | 4 | 2019 | 4655 | 0.250 |
Why?
|
| Sleep | 2 | 2018 | 4796 | 0.220 |
Why?
|
| Pilot Projects | 11 | 2024 | 8730 | 0.210 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1439 | 0.210 |
Why?
|
| Models, Neurological | 1 | 2010 | 1784 | 0.200 |
Why?
|
| Tai Ji | 2 | 2017 | 291 | 0.190 |
Why?
|
| Program Development | 2 | 2020 | 1296 | 0.180 |
Why?
|
| Environment | 2 | 2020 | 1126 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2444 | 0.180 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 2913 | 0.160 |
Why?
|
| Social Isolation | 2 | 2012 | 369 | 0.160 |
Why?
|
| Yoga | 2 | 2013 | 281 | 0.150 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 285 | 0.150 |
Why?
|
| Psychotherapy | 2 | 2020 | 1656 | 0.150 |
Why?
|
| Indazoles | 1 | 2000 | 306 | 0.150 |
Why?
|
| Cyclic GMP | 1 | 1999 | 395 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 11930 | 0.150 |
Why?
|
| Self Care | 3 | 2018 | 798 | 0.140 |
Why?
|
| Cognition | 1 | 2015 | 7066 | 0.140 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 2411 | 0.140 |
Why?
|
| Videoconferencing | 1 | 2018 | 207 | 0.130 |
Why?
|
| Hospitals, General | 1 | 2020 | 807 | 0.130 |
Why?
|
| Male | 36 | 2024 | 364781 | 0.130 |
Why?
|
| Ambulatory Care | 2 | 2006 | 2780 | 0.130 |
Why?
|
| Social Adjustment | 2 | 2011 | 636 | 0.130 |
Why?
|
| Veterans | 2 | 2020 | 2671 | 0.130 |
Why?
|
| Fear | 1 | 2024 | 1494 | 0.130 |
Why?
|
| Job Satisfaction | 1 | 2019 | 549 | 0.120 |
Why?
|
| Morale | 1 | 2015 | 13 | 0.120 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2014 | 36 | 0.120 |
Why?
|
| Healthy People Programs | 1 | 2015 | 54 | 0.120 |
Why?
|
| Adult | 30 | 2024 | 223542 | 0.120 |
Why?
|
| Feasibility Studies | 5 | 2024 | 5308 | 0.120 |
Why?
|
| Female | 34 | 2024 | 396943 | 0.110 |
Why?
|
| Health Personnel | 2 | 2019 | 3384 | 0.110 |
Why?
|
| Humans | 45 | 2024 | 768451 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 7863 | 0.110 |
Why?
|
| Workplace | 1 | 2019 | 872 | 0.110 |
Why?
|
| Group Processes | 1 | 2014 | 228 | 0.100 |
Why?
|
| Middle Aged | 23 | 2024 | 223418 | 0.100 |
Why?
|
| Amygdala | 1 | 2020 | 1382 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2013 | 2146 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 1013 | 0.100 |
Why?
|
| Frontal Lobe | 2 | 2009 | 1427 | 0.100 |
Why?
|
| Occupational Health | 1 | 2018 | 814 | 0.100 |
Why?
|
| Housing, Animal | 1 | 2011 | 47 | 0.100 |
Why?
|
| Focus Groups | 1 | 2017 | 1448 | 0.090 |
Why?
|
| Sleep Deprivation | 1 | 2018 | 848 | 0.090 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2004 | 490 | 0.090 |
Why?
|
| Quality of Life | 6 | 2019 | 13497 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2015 | 651 | 0.090 |
Why?
|
| Hydrocortisone | 2 | 2015 | 1836 | 0.090 |
Why?
|
| Psychometrics | 3 | 2017 | 3072 | 0.090 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 2785 | 0.080 |
Why?
|
| Military Personnel | 1 | 2019 | 1264 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2015 | 2508 | 0.080 |
Why?
|
| Health Resources | 1 | 2015 | 950 | 0.080 |
Why?
|
| Cyclohexanols | 1 | 2009 | 126 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2014 | 764 | 0.080 |
Why?
|
| Attitude | 1 | 2013 | 773 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2017 | 6035 | 0.080 |
Why?
|
| Aged | 13 | 2024 | 171520 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 600 | 0.070 |
Why?
|
| Urban Population | 1 | 2015 | 2047 | 0.070 |
Why?
|
| Internet | 1 | 2018 | 3123 | 0.070 |
Why?
|
| Brain | 2 | 2010 | 27438 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 9425 | 0.070 |
Why?
|
| Thalamus | 1 | 2012 | 1051 | 0.060 |
Why?
|
| Schools | 1 | 2015 | 1496 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2020 | 9382 | 0.060 |
Why?
|
| Child Behavior | 1 | 2011 | 862 | 0.060 |
Why?
|
| Emotions | 1 | 2017 | 2773 | 0.060 |
Why?
|
| Quinolones | 1 | 2009 | 382 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9642 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2003 | 433 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2015 | 2526 | 0.060 |
Why?
|
| Breast | 1 | 2013 | 1976 | 0.060 |
Why?
|
| Health Promotion | 1 | 2015 | 2215 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 1466 | 0.050 |
Why?
|
| Treatment Outcome | 11 | 2017 | 65409 | 0.050 |
Why?
|
| Adolescent | 7 | 2015 | 89168 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 3104 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2009 | 6309 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 3237 | 0.050 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 1439 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2018 | 8538 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 4636 | 0.050 |
Why?
|
| Overweight | 1 | 2013 | 2428 | 0.050 |
Why?
|
| Autistic Disorder | 1 | 2011 | 1240 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2013 | 2901 | 0.050 |
Why?
|
| Inpatients | 1 | 2013 | 2561 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4841 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3408 | 0.050 |
Why?
|
| Weight Loss | 1 | 2013 | 2710 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2020 | 54 | 0.040 |
Why?
|
| Palliative Care | 1 | 2015 | 3644 | 0.040 |
Why?
|
| Drug Resistance | 2 | 2003 | 1599 | 0.040 |
Why?
|
| Wound Healing | 1 | 2011 | 2819 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 39430 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 40271 | 0.040 |
Why?
|
| Hippocampus | 1 | 2012 | 3783 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2018 | 54914 | 0.040 |
Why?
|
| Young Adult | 5 | 2020 | 60045 | 0.040 |
Why?
|
| Crime | 1 | 2020 | 206 | 0.040 |
Why?
|
| Suicide, Attempted | 1 | 2008 | 1409 | 0.040 |
Why?
|
| Free Radicals | 1 | 1999 | 238 | 0.040 |
Why?
|
| Insulin | 1 | 2013 | 6606 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 285 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2546 | 0.040 |
Why?
|
| Noise | 1 | 2020 | 292 | 0.040 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2000 | 244 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 26351 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8611 | 0.040 |
Why?
|
| Catalysis | 1 | 1999 | 769 | 0.040 |
Why?
|
| Models, Chemical | 1 | 1999 | 611 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 1755 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2012 | 6740 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2019 | 750 | 0.030 |
Why?
|
| Vasculitis | 1 | 2020 | 524 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1999 | 911 | 0.030 |
Why?
|
| Aging | 1 | 2015 | 8761 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2009 | 3077 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 59680 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2000 | 4220 | 0.030 |
Why?
|
| Universities | 1 | 2020 | 1007 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15638 | 0.030 |
Why?
|
| Kinetics | 2 | 2000 | 6348 | 0.030 |
Why?
|
| Desipramine | 2 | 2004 | 183 | 0.030 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 1993 | 76 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 3073 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2009 | 3278 | 0.030 |
Why?
|
| Lithium Carbonate | 2 | 2004 | 179 | 0.030 |
Why?
|
| Denmark | 1 | 2015 | 778 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 1158 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3594 | 0.030 |
Why?
|
| Operon | 1 | 1993 | 372 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14766 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 457 | 0.020 |
Why?
|
| Allostasis | 1 | 2013 | 73 | 0.020 |
Why?
|
| Dance Therapy | 1 | 2011 | 8 | 0.020 |
Why?
|
| Leucine | 1 | 1993 | 549 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1878 | 0.020 |
Why?
|
| Drug Therapy, Combination | 3 | 2009 | 6320 | 0.020 |
Why?
|
| Awareness | 1 | 2015 | 654 | 0.020 |
Why?
|
| Personality Inventory | 2 | 2004 | 1019 | 0.020 |
Why?
|
| Saliva | 1 | 2015 | 854 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8201 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1643 | 0.020 |
Why?
|
| Fatigue | 1 | 2018 | 1556 | 0.020 |
Why?
|
| Antimanic Agents | 2 | 2004 | 524 | 0.020 |
Why?
|
| Music Therapy | 1 | 2011 | 111 | 0.020 |
Why?
|
| Protein Binding | 2 | 2000 | 9376 | 0.020 |
Why?
|
| Religion | 1 | 2013 | 377 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81834 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2008 | 1994 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 548 | 0.020 |
Why?
|
| Immune System | 1 | 2013 | 801 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15460 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1971 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1993 | 1139 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1797 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2018 | 3115 | 0.020 |
Why?
|
| Animals | 5 | 2014 | 169418 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3771 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 2339 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2863 | 0.020 |
Why?
|
| Checklist | 1 | 2014 | 843 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2696 | 0.020 |
Why?
|
| Social Environment | 1 | 2011 | 1026 | 0.020 |
Why?
|
| Gene Expression | 1 | 1999 | 7605 | 0.020 |
Why?
|
| Rats | 2 | 2012 | 23839 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1409 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 21156 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 24311 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4533 | 0.020 |
Why?
|
| Attention | 1 | 2015 | 2423 | 0.020 |
Why?
|
| Cell Line | 1 | 1999 | 15609 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3794 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1892 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2018 | 41797 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10784 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2048 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15965 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9507 | 0.010 |
Why?
|
| Drug Therapy | 1 | 2004 | 504 | 0.010 |
Why?
|
| Mental Health | 1 | 2015 | 3271 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 2003 | 411 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2008 | 2268 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 8559 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2003 | 993 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1993 | 3861 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3624 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 3484 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12450 | 0.010 |
Why?
|
| Mitochondria | 1 | 2013 | 3672 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 7134 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10494 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2004 | 1839 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 9623 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1999 | 23638 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6657 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10358 | 0.010 |
Why?
|
| Neoplasms | 1 | 2024 | 22386 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 9066 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2004 | 2433 | 0.010 |
Why?
|
| Leucine-Responsive Regulatory Protein | 1 | 1993 | 2 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1993 | 12174 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 851 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1993 | 575 | 0.010 |
Why?
|
| Obesity | 1 | 2013 | 13065 | 0.010 |
Why?
|
| DNA Primers | 1 | 1993 | 2826 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1993 | 1474 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2011 | 42623 | 0.000 |
Why?
|
| Plasmids | 1 | 1993 | 2269 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 4175 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 82045 | 0.000 |
Why?
|
| Escherichia coli Proteins | 1 | 1993 | 1061 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 20231 | 0.000 |
Why?
|
| Prevalence | 1 | 2003 | 15880 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 36840 | 0.000 |
Why?
|
| United States | 1 | 2013 | 73121 | 0.000 |
Why?
|
| Child | 1 | 2011 | 80863 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 12428 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1993 | 5803 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 17647 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1993 | 7599 | 0.000 |
Why?
|
| Risk Factors | 1 | 2003 | 74915 | 0.000 |
Why?
|